FIELD: medicine. SUBSTANCE: method involves using several synthetic peptides in combination as antigen component of immunodiagnostic test system in a whole antigen system. The peptides correspond to different antigen determinants of HTLV-I proteins and have immune reactivity of different specificity with respect to anti-HTLV-I antibodies allowing to detect total presence of different specificity antibodies corresponding to different antigen determinants of HTLV-I in biological liquid sample under study. EFFECT: enhanced diagnostic specificity of the method. 4 cl, 3 tbl
Authors
Dates
1995-12-10—Published
1992-07-29—Filed